Biosynex

Who we are

Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and is specialized in the design and distribution of rapid diagnostic tests (RDT). Today, BIOSYNEX is the leader of the RDT French market.

Fast and easy to use, these RDTs are commercialized in France and in some 60 countries through local distributors. By targeting the general public and health professionals, BIOSYNEX brings concrete and effective answers to public health issues at the heart of today’s preoccupations.

Self-tests :

Self-tests are the general public version of RDTs and are available in pharmacies. These allow self-monitoring for multiple applications, such as: HIV, pregnancy diagnosis, ovulation period, male fertility, urinary tract infections, vaginal infections, etc.

Professional tests :

RDTs may be used by health professionals (analytical laboratories, doctors) for diagnostic orientation. They allow an appropriate management of the patient both in consultation and in emergency. As an example, BIOSYNEX has been supplying around 50,000 liberal doctors with a strep test, Streptatest® for the last few years as part of the call for tenders launched by the National Health Insurance Fund for Employees (CNAMTS), thus improving significantly the screening for bacterial angina and limiting the overconsumption of antibiotics.

RDTs may also be used in the analytical laboratory for the realization of piecemeal tests.

BIOSYNEX also commercializes a panel of instruments and machines which can be used in POC, as well as other tests for analytical laboratories based on technologies for confirmation diagnosis such as immunoblotting or molecular biology.

Our values

Contribute to public health through the development of innovative solutions for rapid, simple and practical diagnostics in order to prevent, diagnose and enable appropriate patient care management.